Evidence map›Paper›PMID 33215721›Full record

ArticleJournal of medical virology2021

Ketamine in COVID-19 patients: Thinking out of the box.

Karolina Akinosoglou, Athanasios Gogos, Charalambos Papageorgiou, Elias Angelopoulos, Charalambos Gogos

Open access · bronzeAbstract readLetter
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.European archives of psychiatry and clinical neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Karolina AkinosoglouDepartment of Internal Medicine and Infectious Diseases, University of Patras, Patras, Greece.ORCID http://orcid.org/0000-0002-4289-9494
Athanasios GogosDepartment of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.
Charalambos PapageorgiouDepartment of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.
Elias AngelopoulosDepartment of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.
Charalambos GogosDepartment of Internal Medicine and Infectious Diseases, University of Patras, Patras, Greece.
National and Kapodistrian University of Athens · GRUniversity of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentCOVID-19HumansKetamineMental DisordersKetamine

Identifiers

PMID33215721
PMCPMC7753268
OpenAlexW3106536098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.